Medlab Central
Medlab Central is a New Zealand regional medical laboratory diagnostic services provider operating four centres across the central North Island, delivering pathology testing to community patients and three DHB-funded public hospitals under Sonic Healthcare ownership.
- Company typePrivate
- Founded1994
- HeadquartersNapier, New Zealand
- Headcount101–250
- GTM typeB2B
- OfferingServices
What Medlab Central does
Medlab Central Limited is a regional medical laboratory diagnostic services provider operating four centres across the central and lower North Island of New Zealand: Hawkes Bay, Gisborne, Palmerston North, and Whanganui. The company tests samples referred by general practitioners, specialists, midwives, and other medical referrers, serving a population of approximately 250,000 across the Manawatu, Horowhenua, Otaki, Tararua, Wairarapa, Wanganui, Tairawhiti districts and Hawke's Bay. Its service portfolio spans Clinical Biochemistry and Serology, Cytology (approximately 40,000 specimens annually), Haematology, Histology (including immunohistochemistry and special stains), Microbiology, Molecular Diagnostics (PCR-based testing for SARS-CoV-2, Chlamydia trachomatis, Neisseria gonorrhoeae, and high-risk HPV), and Mortuary services.
Operationally, the Palmerston North, Gisborne, and Whanganui laboratories are co-located inside their respective public hospitals and also serve as community specimen collection sites. The Palmerston North site additionally functions as the regional referral centre for oncology patients in the lower central North Island. Medlab Central's mortuary is one of only four classified Forensic facilities in New Zealand and operates under the National Forensic Pathology Service and Justice Department. All laboratories hold International Accreditation New Zealand (IANZ) accreditation.
The business model is dominated by publicly funded laboratory testing delivered through contracts with three District Health Boards — MidCentral, Whanganui, and Tairawhiti — supplemented by community referrals and a limited self-pay, direct-to-patient testing channel. With 350+ staff (including 14 specialist pathologists and 4 registrars) and approximately 50 daily courier specimen pickups, Medlab Central is a wholly-owned subsidiary of Sonic Healthcare Limited, an ASX-listed Top 50 company headquartered in Sydney and the world's third-largest pathology/laboratory medicine operator. Medlab Central operates under Sonic's Medical Leadership philosophy and Foundation Principles.
Medlab Central firmographics
Firmographics- Name
- Medlab Central
- Legal name
- Medlab Central Limited
- Website
- https://medlabcentral.co.nz
- Company type
- Private
- Founded year
- 1994
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Medlab Central is a New Zealand regional medical laboratory diagnostic services provider operating four centres across the central North Island, delivering pathology testing to community patients and three DHB-funded public hospitals under Sonic Healthcare ownership.
- Ownership category
- akta.pro rank
Medlab Central industry classification
Industry- Product category
- Diagnostic Pathology Services
- NAICS
- Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215)
- SIC
- Services-Medical Laboratories (8071)
- akta.pro primary industry
- Central Laboratory Services (Core Lab Operations) (HLAGAEAA)
- akta.pro secondary industries
- Sample Logistics, Biorepository & IVD Kit Management (Trial Support) (HLAGAEAI), Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays) (HLAAAMAC)
Keywords
Where Medlab Central is headquartered
LocationHeadquarters
- HQ city
- Napier
- HQ country
- New Zealand
- HQ region
- Oceania
Offices4 records
Markets served
Medlab Central business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure
Revenue model
- Publicly Funded Laboratory Testing: Diagnostic laboratory services funded through New Zealand's public health system. Services provided to community patients and public hospitals (DHBs) including MidCentral DHB, Whanganui DHB, and Tairawhiti DHB. Patient eligibility for public funding of medical laboratory testing is determined by the health system.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Direct patient testing available for self-referred tests |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels4 records
Medlab Central product offering
Product offeringCore offering
Medlab Central provides medical diagnostic laboratory services across four regional centers in New Zealand's lower North Island, serving both community-collected and hospital-collected specimens. The service portfolio spans anatomical pathology, microbiology, biochemistry, and specialist testing including PCR, immunohistochemistry, and special stains, supported by a regional oncology referral service and a forensic mortuary. Its 14 pathologists and 4 registrars deliver diagnostic reporting to GPs, specialists, and public hospitals, primarily funded through New Zealand's District Health Boards.
Product overview
Medlab Central is a medical laboratory diagnostic service provider operating four centres across the central North Island of New Zealand: Hawkes Bay, Gisborne, Palmerston North, and Whanganui. The company offers a unified pathology service comprising specialized departments including Clinical Biochemistry, Serology/Immunology, Cytology, Haematology, Histology, Microbiology, Molecular Diagnostics, and Mortuary services. The main Medlab Central laboratory in Palmerston North also serves as the regional referral centre for oncology patients. Services are delivered through multiple lab locations (Medlab Central Palmerston North, TLab Gisborne, Medlab Whanganui) that operate within local public hospitals and serve both community and hospital patients. The molecular diagnostics department performs PCR-based testing for infectious diseases including COVID-19, STIs, and HPV.
Differentiator
Problem solved
Functional benefit
Products and services
- Diagnostic pathology services Core anatomical pathology, microbiology, and biochemistry diagnostic testing delivered through four regional laboratories to hospital patients, GPs, and specialists across the lower North Island of New Zealand.
- Specialist molecular and immunohistochemistry testing Specialist diagnostic testing including PCR, immunohistochemistry, and special stains, used by referring clinicians and DHBs for complex diagnostic cases across the regional network.
- Regional oncology referral service Oncology referral pathology service enabling cancer diagnostics and treatment-pathway support for clinicians and DHBs in the lower North Island region.
- Forensic mortuary and pathology service Forensic pathology and mortuary service provided to coronial and police authorities across the lower North Island, delivered by specialist pathologists.
- Community specimen collection Walk-in specimen collection services for community-referred patients, supporting GP-requested pathology testing across the regional catchment.
Quantifiable outcome
- 40,000 cytology specimens processed annually including 35,000 gynaecological samples and 5,000 non-gynaecological specimens
- +1 more outcomes
Companies that use Medlab Central
Customer profileNamed customers4 records
Segments4 records
Ideal customer profiles2 records
Medlab Central technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Medlab Central partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- National Forensic Pathology Service of New ZealandcoreMedlab Central mortuary operates within scope of Mid Central DHB and is one of four classified Forensic facilities in New Zealand. Day-to-day running is associated with National Forensic Pathology Service of New Zealand and the Justice Department under the Coroners Act 2006.
- Sonic Healthcare LimitedcoreSonic Healthcare Limited is the parent company of Medlab Central. Headquartered in Sydney, Australia, Sonic is publicly listed on Australian Securities Exchange (Top 50). Third-largest pathology/laboratory medicine company globally with operations in eight countries, employing 38,000 people including 900+ specialist pathologists.
Scale indicators6 records
Recent moves6 records
Expansion highlights5 records
Medlab Central competitors and assessment
Company assessmentDirect peers
- Pathlab: New Zealand community pathology provider serving the Bay of Plenty and Waikato regions. Comparable in scale and service mix (community and hospital testing across multiple specialties) and competes in adjacent regional catchments.
- Canterbury Health Laboratories: Hospital-based diagnostic laboratory operated by Canterbury DHB serving the South Island. Comparable as a multi-specialty regional referral pathology lab with academic/teaching hospital affiliations and public funding model.
- Labtests: Auckland-based community pathology provider and fellow Sonic Healthcare subsidiary operating across the upper North Island. Directly comparable as a New Zealand regional pathology service with similar DHB relationships and Sonic-backed Medical Leadership operating model.
- Southern Community Laboratories: New Zealand community pathology provider covering the South Island and lower North Island. Directly comparable as a multi-site community and hospital laboratory with DHB contracts and a similar test menu including molecular diagnostics.
- Douglas Hanly Moir (Sonic Australia): Sonic Healthcare's flagship Australian pathology practice operating across NSW. Comparable as a fellow Sonic subsidiary with Medical Leadership philosophy, multi-site regional coverage, and similar pathologist-staffed service model.
- Waikato Pathology: Hospital-based regional pathology service operated by Waikato DHB. Comparable as a regional referral centre providing multi-specialty diagnostics (including oncology) to a defined catchment via DHB funding.
Broad incumbents
- Healius (formerly Primary Health Care): Australian diagnostic and pathology operator with community collection centres and hospital lab services. Comparable as a larger incumbent pathology platform serving similar GP-referred community testing demand in a trans-Tasman market.
- Sonic Healthcare: Australian-listed parent company and one of the world's largest pathology operators with operations in eight countries. Comparable as the broader portfolio player whose Medical Leadership philosophy and group operating model underpin Medlab Central's approach and constrain its strategic autonomy.
- ACL (Australian Clinical Labs): Australian pathology provider with community collection network and hospital laboratory contracts. Comparable as a multi-site regional pathology operator with similar DHB-equivalent (state health) relationships and test menu breadth.
Others
- National Forensic Pathology Service: New Zealand's national forensic pathology service that Medlab Central's mortuary operates under. Comparable as a strategic partner/regulator in the highly specialised forensic pathology niche where Medlab Central holds one of only four classified facility licences.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Medlab Central social profiles
Digital presenceMedlab Central compliance and trust
Trust signalCompliance1 record
Medlab Central financial estimates
Financial estimateRevenue estimate
Valuation estimate
Medlab Central leadership team
Management profileNumber of profiles
Profiles2 records
Medlab Central subsidiaries and ownership
Company hierarchySubsidiaries1 record
Medlab Central funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Medlab Central M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Medlab Central
What does Medlab Central do?
Medlab Central provides medical diagnostic laboratory services across four regional centers in New Zealand's lower North Island, serving both community-collected and hospital-collected specimens. The service portfolio spans anatomical pathology, microbiology, biochemistry, and specialist testing including PCR, immunohistochemistry, and special stains, supported by a regional oncology referral service and a forensic mortuary. Its 14 pathologists and 4 registrars deliver diagnostic reporting to GPs, specialists, and public hospitals, primarily funded through New Zealand's District Health Boards.
Is Medlab Central a public or private company?
Medlab Central is a private company. It is classified as corporate owned and is currently operating.
When was Medlab Central founded?
Medlab Central was founded in 1994. It employs 101 to 250 people.
Where is Medlab Central based?
Medlab Central is headquartered in Napier, New Zealand, in the Oceania region.
How does Medlab Central make money?
One revenue line is on record: publicly Funded Laboratory Testing.
Who are Medlab Central's main competitors?
Direct peers on record are Pathlab, Canterbury Health Laboratories, Labtests, Southern Community Laboratories, Douglas Hanly Moir (Sonic Australia) and Waikato Pathology. Broad incumbents are Healius (formerly Primary Health Care), Sonic Healthcare and ACL (Australian Clinical Labs). National Forensic Pathology Service is listed as an others.
Does Medlab Central have an API?
No public API is recorded for Medlab Central.
What industry is Medlab Central in?
Medlab Central's product category is Diagnostic Pathology Services. Its primary akta.pro industry code is HLAGAEAA, Central Laboratory Services (Core Lab Operations), with a secondary code of HLAGAEAI, Sample Logistics, Biorepository & IVD Kit Management (Trial Support). Its NAICS code is 621511 and its SIC code is 8071.